Mavoglurant for alcohol craving in heavy drinkers
Part of Mental health clinical trials.
This trial tests whether a medication called mavoglurant can reduce alcohol cravings and drinking in people who are heavy drinkers with alcohol use disorder and are not looking for treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 50 years old
- You are a heavy drinker (men: 30-70 drinks/week, women: 20-65 drinks/week)
- You have been diagnosed with moderate or severe alcohol use disorder
- You are not currently seeking treatment for alcohol and haven't been in treatment in the last 6 months
- You do not have a current substance use disorder other than tobacco or mild cannabis
- You are generally healthy, especially your liver, and are not pregnant or nursing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a structured training program for young adults who’ve been drinking heavily, to help them reduce drinking or quit. You’ll be asked to complete daily short check-ins and follow study instructions, and you may be randomly assigned to different parts of the program.
This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.
This early-stage study uses brain scans to understand how brain signaling tied to alcohol vulnerability works, and it tests mavoglurant, a medicine that blocks a brain receptor. Results may help researchers learn why some people are more vulnerable to alcohol problems.
This study tests whether a drug called apremilast can help people who drink heavily reduce their alcohol use. You will take the medication daily for several weeks and attend study visits to track your progress.
This trial tests if a blood pressure medication called nimodipine can help reduce alcohol drinking in people with moderate to severe alcohol use disorder. You'll take the medication or a placebo and participate in drinking sessions to see how it affects your alcohol intake.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
Hear when a new Alcohol Consumption trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.